These results highlighted the value of mpMRI in the initial examination of low- and intermediate-risk PCa, and the possible conditions in which PCa patients might benefit from undergoing a combination of both 68Ga-PSMA PET/CT and mpMRI. This evidence concerns the gene FOLH1 and posterior cortical atrophy.